United Therapeutics Corporation Performance Overview
United Therapeutics Corporation (ticker: UTHR) experienced a modest increase in its share price during the 24‑hour trading period ending at 08:00 AM Central Europe on Wednesday, 21 April 2026. The stock closed 1.88 % higher, trading at USD 553.88 on major exchanges.
- Shares outstanding: 42.9 million
- Market capitalization: USD 22.9 billion
- Volume traded (last 24 hours): USD 269.1 million worth of shares
- Year‑to‑date gain: 10.15 % since the previous month‑end
- 200‑day simple moving average: USD 527.28
- 52‑week high: USD 609.35 (recorded 5 June 2026)
- 52‑week low: USD 409.07 (recorded 28 October 2025)
The company is listed on the Nasdaq stock exchange and reports its financials on the website www.unither.com . United Therapeutics specializes in developing pharmaceuticals for vascular diseases, particularly pulmonary hypertension and peripheral vascular disease, and markets stable synthetic prostacyclin formulations that are administered orally or subcutaneously.
Comparative Performance of Related Stocks (Last 24 hours)
| Company | Ticker | Price Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Citizens Financial Group | CFG | –0.95 % | USD 64.22 | USD 26.7 bn | 13.72 |
| American Water Works | AWK | –1.02 % | USD 135.79 | USD 26.8 bn | 23.36 |
| West Pharmaceutical Services | WST | –0.03 % | USD 388.78 | USD 27 bn | 48.87 |
| CenterPoint Energy | CNP | –2.44 % | USD 40.24 | USD 26.7 bn | 24.14 |
| Hewlett Packard Enterprise | HPQ | +0.77 % | USD 31.21 | USD 27.1 bn | 11.47 |
The table summarizes the recent price movements, market capitalization, and price‑to‑earnings ratios of five companies that are often monitored in conjunction with United Therapeutics.